CSI Market
Sign In | Register

Zyversa Therapeutics Inc (ZVSA) Annual Balance Sheets

Annual · GAAP · USD millions
Access ZVSA quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Zyversa Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.10
Security Deposit0.00
Deposits Assets, Current AS0.01
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.23
Total Current Assets0.35
Equipment/Property/Plant Net0.00
Goodwill net0.00
Intangible Assets0.00
Deferred Tax Assets, in Process Research and Development0.00
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets0.35
Liabilities
Accounts Payable, Current AC10.12
Accrued Liabilities, Current AC2.61
Financial Instruments0.00
Other Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities12.73
Total Long-term Debt0.00
Employee Benefit Plans, Noncurrent0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
DeferredIncomeTaxLiabilitiesNet-
Warrant Liability-
Total Liabilities12.73
Stockholders' Equity
Class B Common Stock Value-
Common Stock Value0.00
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock125.20
Retained Earnings / Accumulated Deficit-137.58
Other Equity0.00
Common Stockholder's Equity-12.39
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-12.39
Liabilities & Stockholder's Equity0.35
4 historic quarters locked

Sign in to unlock the full Zyversa Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Zyversa Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014271

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License